"10.1371_journal.pone.0070715","plos one","2013-08-08T00:00:00Z","Paul T Hamilton; Michelle S Jansen; Sathya Ganesan; R Edward Benson; Robin Hyde-DeRuyscher; Wayne F Beyer; Joseph C Gile; Shrikumar A Nair; Jonathan A Hodges; Hanne Grøn","Department of Microbiology, North Carolina State University, Raleigh, North Carolina, United States of America; Affinergy, LLC, Research Triangle Park, North Carolina, United States of America; Platform Technology and Science, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America; Manufacturing Sciences, Biogen Idec, Research Triangle Park, North Carolina, United States of America; QNS Group, LLC, Durham, North Carolina, United States of America; Gile Surgical Support, Bangor, Maine, United States of America; Haemophilia Biochemistry, Novo Nordisk, Måløv, Denmark","Conceived and designed the experiments: WB HG SG SN MJ RB RH JH PH. Performed the experiments: WB SG SN MJ RB RH JG. Analyzed the data: WB HG SG SN MJ RB RH JH PH. Contributed reagents/materials/analysis tools: WB RB. Wrote the paper: PH.","MSJ, SG, SAN, and JH are employees of Affinergy. PTH is an employee of North Carolina State University. REB is an employee of GlaxoSmithKline. RHD is an employee of Biogen Idec. WFB is an employee of QNS Group. JCG is an employee of Gile Surgical Support. HG is an employee of Novo Nordisk. The BMP-binding peptides are contained in a family of issued and pending patents (see United States Patent number 7,572,766) assigned to Affinergy. There are no marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","08","Paul T Hamilton","PTH",10,TRUE,9,7,9,1,TRUE,TRUE,FALSE,0,NA,FALSE
